Insurance and quality of care for children with acute asthma

T G Ferris1, E F Crain, E Oken

  • 1Institute for Health Policy, Massachusetts General Hospital, Boston, USA.

Insights

Children with managed care insurance received comparable quality of care and experienced similar outcomes for acute asthma compared to those with indemnity insurance. Uninsured children faced significantly lower quality of care.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Services Research
  • Health Insurance

Background:

  • Insurance significantly impacts healthcare quality and outcomes.
  • Managed care organizations aim to reduce emergency department (ED) use for acute conditions like asthma.
  • Comparisons of care quality across different insurance types are limited.

Purpose of the Study:

  • To compare pre-ED care quality, acute asthma severity, and short-term outcomes among children with different insurance types.
  • To analyze differences in ED utilization and primary care access based on insurance status.

Main Methods:

  • Prospective data from 965 children with acute asthma across 36 EDs.
  • Comparison of 7 quality measures, acute severity, and outcomes (length of stay, relapse, ongoing symptoms) across managed care, indemnity, Medicaid, and uninsured groups.
  • Multivariate regression controlled for demographic and clinical factors.

Main Results:

  • Managed care and indemnity groups showed similar quality of care and outcomes.
  • Medicaid and uninsured children had significantly lower quality of care, including less primary care provider (PCP) use and higher ED utilization for asthma.
  • Children with managed care presented with more severe acute asthma compared to other groups.
  • No significant differences in hospital length of stay, relapse, or ongoing exacerbation were observed across insurance types.

Conclusions:

  • Children with managed care insurance receive comparable quality of care and have similar asthma outcomes to those with indemnity insurance.
  • Uninsured children consistently experience poorer quality of care.
  • Despite higher acute severity, managed care patients did not have worse outcomes than indemnity patients.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...